Fred Colen Appointed Chief Executive Officer of Neovasc Inc.
Recognized Multinational Senior Executive Poised to Drive Commercialization and Clinical Advances NASDAQ, TSX: NVCN VANCOUVER, Jan. 22, 2018 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (Nasdaq, TSX: NVCN), a front-runner in minimally invasive transcatheter mitral valve technologies today announced that its board of directors (the "Board") has...
Read More